More articles from Lung cancer

International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
Paul Martin Putora, Pawel Leskow, Fiona McDonald, Tim Batchelor, Matthiew Evison

ERJ Open Research Jan 2020, 6 (1) 00159-2019; DOI: 10.1183/23120541.00159-2019
Routine neck ultrasound by respiratory physicians in the diagnosis and staging of patients with lung cancer and mediastinal lymphadenopathy: a prospective pilot study
Mohammed Ahmed, Cyrus Daneshvar, David Breen

ERJ Open Research Jan 2020, 6 (1) 00180-2019; DOI: 10.1183/23120541.00180-2019
Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis
Deirdre M.H.J. ten Berge, Daniel P. Hurkmans, Ilse den Besten, Jeroen S. Kloover, Ron H.J. Mathijssen, Reno Debets, Egbert F. Smit, Joachim G.J.V. Aerts

ERJ Open Research Oct 2019, 5 (4) 00179-2019; DOI: 10.1183/23120541.00179-2019
Systematic endobronchial ultrasound-guided transbronchial needle aspiration improves radiotherapy planning in non-small cell lung cancer
Aidan Joseph Cole, Nicholas Hardcastle, Guy-Anne Turgeon, Roshini Thomas, Louis B. Irving, Barton R. Jennings, David Ball, Tomas Kron, Daniel P. Steinfort, Shankar Siva

ERJ Open Research Jul 2019, 5 (3) 00004-2019; DOI: 10.1183/23120541.00004-2019
Microbiota profile of Non-small Cell Lung Cancer (NSCLC): the study of a large cohort
Sílvia Gomes, Bruno Cavadas, Joana Ferreira, Patrícia Marques, Catarina Monteiro, Maria Sucena, Catarina Sousa, Luís Vaz Rodrigues, Gilberto Teixeira, Paula Pinto, Tiago Tavares Abreu, Cristina Barbara, Julio Semedo, Leonor Mota, Ana Sofia Carvalho, Rune Rune Matthiesen, Luísa Pereira, Susana Alves Seixas

ERJ Open Research Mar 2019, 5 (suppl 2) PP101; DOI: 10.1183/23120541.lungscienceconference-2019.PP101
High frequency of infection of lung cancer patients with the parasite Toxoplasma gondii
Jaroslav Bajnok, Muyassar Tarabulsi, Helen Carlin, Kevin Bown, Thomas Southworth, Josiah Dungwa, Dave Singh, Zhao-Rong Lun, Lucy Smyth, Geoff Hide

ERJ Open Research Apr 2019, 5 (2) 00143-2018; DOI: 10.1183/23120541.00143-2018
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions
Karlijn Hummelink, Mirte Muller, Theodora C. Linders, Vincent van der Noort, Petra M. Nederlof, Paul Baas, Sjaak Burgers, Egbert F. Smit, Gerrit A. Meijer, Michel M. van den Heuvel, Daan van den Broek, Kim Monkhorst

ERJ Open Research Feb 2019, 5 (1) 00016-2019; DOI: 10.1183/23120541.00016-2019
Cancer gene mutations in congenital pulmonary airway malformation patients
Jacob Shujui Hsu, Ruizhong Zhang, Fanny Yeung, Clara S.M. Tang, John K.L. Wong, Man-Ting So, Huimin Xia, Pak Sham, Paul K. Tam, Miaoxin Li, Kenneth K.Y. Wong, Maria-Mercè Garcia-Barcelo

ERJ Open Research Feb 2019, 5 (1) 00196-2018; DOI: 10.1183/23120541.00196-2018
30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?
Jacobus Adrianus Burgers, Ronald Alphons Damhuis

ERJ Open Research Oct 2018, 4 (4) 00030-2018; DOI: 10.1183/23120541.00030-2018
New drugs in thoracic oncology: needs and knowledge – an online ERS Lung Cancer Assembly survey
Thierry Berghmans, Matthew Evison, Torsten Gerriet Blum, Nir Peled, Jacques Cadranel

ERJ Open Research Jul 2018, 4 (3) 00040-2018; DOI: 10.1183/23120541.00040-2018

Main menu

User menu

Search

More articles from Lung cancer

Pages

Contact us